Micro-computed tomography for the quantification of blocked fibers in hemodialyzers by Vanommeslaeghe, Floris et al.
1SCieNTiFiC REPORtS |  (2018) 8:2677  | DOI:10.1038/s41598-018-20898-w
www.nature.com/scientificreports
Micro-computed tomography for 
the quantification of blocked fibers 
in hemodialyzers
Floris Vanommeslaeghe1, Wim Van Biesen1, Manuel Dierick2, Matthieu Boone2, Annemieke 
Dhondt1 & Sunny Eloot1
A novel technique based on micro-CT scanning is developed to quantify coagulation in fibers of 
hemodialyzers. This objectivation is needed to allow accurate assessment of thrombogenicity of 
dialyzers used during hemodialysis, for example when comparing different strategies to avoid 
coagulation and/or fiber blocking. The protocol allowed imaging at a resolution of 25 µm, making 
it possible to count the open, non-coagulated fibers in a non-invasive way. In 3 fresh, non-used 
FX600 hemodialyzers, patent fiber counts were extremely consistent (10748 ± 2). To illustrate 
the potential of this technique, different dialysis parameters currently used as surrogates for fiber 
blocking were evaluated during 20 hemodialysis sessions. After dialysis, the FX600 dialyzers were 
visually scored for clotting, dried and subsequently weighed and scanned. The number of patent 
fibers (10003 [8763,10330], range 534–10692) did not correlate with any of the recorded surrogate 
parameters. Micro-CT scanning is a feasible, objective, non-invasive, accurate and reproducible tool 
for quantification of the degree of fiber blocking in a hemodialyzer after use, making it a potential gold 
standard for use in studies on fiber blocking during renal replacement therapies.
Over 2 million people worldwide require renal replacement therapy to sustain life. The vast majority of them 
are treated with hemodialysis, a technique in which patient’s blood is purified by circulating it through an extra-
corporeal circuit containing a hemodialyzer, consisting of around 10000 semi-permeable capillary fibers. The 
patient’s blood flows in the fiber lumen, while an electrolyte water solution (dialysate) flows counter-currently 
around the fibers to optimize the diffusive concentration gradient necessary to drive solute transport. Disordered 
blood flow and contact of the blood with the bio-incompatible material of the fibers activate the coagulation 
cascade leading to clotting and subsequent blocking of the capillary fibers1. This results in a reduction of the 
efficiency of the dialysis procedure, as less fibers remain available for solute exchange. When more pronounced, 
coagulation can even cause loss of the extracorporeal blood volume by complete clotting of the extracorporeal 
circuit, so blood can no longer be returned to the patient. To avoid clotting, appropriate anti-coagulant measures 
must be applied. Hemodialyzers can be constructed to minimally activate coagulation, either by their design or by 
using more biocompatible materials. In addition, substances with anticoagulant properties can be administered 
during the dialysis session. However, overdosing of these anticoagulants can cause bleeding and finding the right 
balance between under- and over-anticoagulation is challenging.
So far, assessment of the degree of fiber blocking during hemodialysis is measured with different surrogate 
parameters, but none of them is objective or validated against a gold standard. Some of these are available online 
during the treatment, such as the dialysis machine parameters venous pressure2,3, transmembrane pressure4 and 
online solute clearance5. Others are assessed offline, such as visual6–10 or software assisted7 dialyzer redness scor-
ing. Also laboratory parameters representing coagulation activity in general6–8,11–13, measured solute clearance6,14, 
evaluation of rinse-back3 or fiber bundle volumes15–17 and electron microscopy9 have been used. None of these 
parameters is robust, objective or accurate, which limits the comparative study of different strategies to reduce 
coagulation and fiber blocking. There is thus a need for an objective, operator-independent and reproducible gold 
standard to determine the extent of fiber blocking during dialysis treatment18. The number of blocked capillary 
fibers most objectively represents the clinical impact of coagulation.
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The present study examines the feasibility and accuracy of micro-computed tomography (micro-CT) to quan-
tify the number of blocked fibers. As illustration, the number of blocked fibers as measured by micro-CT is com-
pared to other surrogate parameters used to assess fiber blocking.
Results
Micro-CT scanning allowed to acquire high quality images of cross-sections of all scanned dialyzers. Individual 
capillary fibers could easily be distinguished and their total number quantified. Fiber counting in corresponding 
cross-sections of the 3 non-used dialyzers resulted in almost exactly the same number of fibers (e.g. 10748 ± 2 in 
the reference slice), as is expected taking into account the high consistency of the manufactural process of bun-
dling fibers in individual dialyzer capsules.
Figure 1 shows images representing different levels of coagulation in different used dialyzers. Complete circuit 
blocking because of dialyzer clotting did not occur during the sessions of the current experiments, but the 20 
Figure 1. Representative CT images of dialyzer cross-sections (reference slice) showing different levels of 
coagulation.
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dialyzers under study represented a broad spectrum of coagulation activation, as reflected by the wide range (534 
to 10692) of fibers remaining open after the dialysis session.
Table 1 shows the number of counted open fibers in the non-used and used dialyzers and this in different 
cross-sections and for different thresholds of open fiber surface areas. Good similarity in counts of open fibers 
remained when images were assessed using different thresholds to define an ‘open fiber’ (i.e. difference ≤1.7%), 
showing the robustness and validity of the technique. Differences in the number of open fibers as counted in 
different cross-sections in the potting were within the clinical relevance (≤6.1%), endorsing the reliability of the 
technique.
Associations were found between the number of open fibers and the post-dialysis dry mass of the dialyzers 
(R² = 0.62), and the visual clotting scores of the dialyzers (R² = 0.41) and venous chambers (R² = 0.34). However, 
none of the online available parameters as indicated on the dialysis machine (i.e. pressures, blood volume moni-
toring and online clearance monitoring) as well as the post dialysis registered rinse-back volume were associated 
with the number of open fibers (Table 2 and Fig. 2).
Discussion
We demonstrate the feasibility to use a self-developed micro-CT technique to assess objectively and in an 
operator-independent manner the blocking of individual fibers in hemodialyzers with great accuracy and repeat-
ability. Using this technique, we demonstrate that currently used parameters, based on data derived from the 
dialysis monitor, visual scoring or post-dialysis mass of the dialyzer are not representative to assess the degree of 
fiber blocking.
The circulation of blood through extracorporeal devices such as hemodialyzers activates the coagulation cas-
cade, which might result in clotting and obstruction of the circuit. In hemodialysis, this progressive blocking of 
fibers within the dialyzer results in a progressive decrease of dialysis performance, and potential loss of blood 
when the circuit becomes completely obstructed. The degree of activation of the coagulation cascade depends on 
the biocompatibility of the dialyzer and the coagulability of the blood. Biocompatibility is in itself a combination 
of design, for example geometry to avoid turbulence, blood stagnation and shear stress, and the type of materials 
used19,20. Coagulability depends upon patient factors, for example presence of inflammation or coagulation disor-
ders, and can be influenced by applying an anticoagulant strategy during the dialysis session. This should however 
be done with caution, as too much anticoagulation might induce bleeding and death of the patient.
Dialyzer
Reference slice,
threshold 70%
2.5 mm from reference slice, 
threshold 70%
Reference slice, threshold 
60%
Reference slice, 
threshold 80%
NON-USED DIALYZERS
 Blanco 1 10746 10748 (0) 10749 (0) 10743 (0)
 Blanco 2 10750 10751 (0) 10751 (0) 10749 (0)
 Blanco 3 10749 10749 (0) 10751 (0) 10745 (0)
 Mean ± SD 10748 ± 2 10749 ± 2 10751 ± 1 10745 ± 3
USED DIALYZERS
 1 5443 5497 (0.5) 5478 (0.3) 5391 (0.5)
 2 7632 8290 (6.1) 7645 (0.1) 7615 (0.2)
 3 10328 10477 (1.4) 10329 (0) 10321 (0.1)
 4 10246 10305 (0.5) 10256 (0.1) 10215 (0.3)
 5 10335 10368 (0.3) 10336 (0) 10323 (0.1)
 6 10228 10391 (1.5) 10232 (0) 10219 (0.1)
 7 8327 8335 (0.1) 8335 (0.1) 8258 (0.6)
 8 534 558 (0.2) 544 (0.1) 352 (1.7)
 9 10041 10134 (0.9) 10043 (0) 10030 (0.1)
 10 9451 9118 (3.1) 9461 (0.1) 9442 (0.1)
 11 10234 10293 (0.5) 10283 (0.5) 10106 (1.2)
 12 6066 6323 (2.5) 6093 (0.4) 5998 (0.5)
 13 10692 10688 (0) 10695 (0) 10682 (0.1)
 14 10587 10656 (0.6) 10588 (0) 10578 (0.1)
 15 8908 9330 (3.9) 8968 (0.6) 8800 (1.0)
 16 10351 10419 (0.6) 10364 (0.1) 10299 (0.5)
 17 8994 8406 (5.5) 9019 (0.2) 8966 (0.3)
 18 10465 10535 (0.7) 10467 (0) 10451 (0.1)
 19 9965 9903 (0.6) 9974 (0.1) 9936 (0.3)
 20 9752 9791 (0.4) 9764 (0.1) 9707 (0.4)
 Median [IQR] 10003 [8763;10330] 10019 [8388;10398] 10009 [8810;10331] 9983 [8665;10305]
Table 1. Number of open fibers as counted in the different scanned dialyzers (percentage of difference in open 
fibers versus those in the reference slice, and related to the total number of fibers).
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Different designs of filters and anticoagulant strategies have been developed, but comparing the balance of 
efficacy and safety between different designs and strategies is hampered by the lack of a well-established and 
objective tool to evaluate the resulting degree of filter blocking in the hemodialyzer. There is thus need for a gold 
Dialyzer
#fibers ref 
slice 70% 
threshold
dialyzer dry 
mass (g)
visual 
scoring 
dialyzer
visual scoring 
venous 
chamber
Rinse back 
volume (mL)
arterial 
pressure pre-
post (mmHg)
venous 
pressure pre-
post (mmHg)
TMP 
post-pre 
(mmHg)
BVM pre-
post (%)
OCM pre-post 
(mL/min)
1 5443 224.0 4 3 220 25 −5 160 7 28
2 7632 222.5 3 2 280 0 −45 80 9 31
3 10328 142.0 1 1 280 10 20 30 4 18
4 10246 176.0 2 1 270 10 −105 55 11 19
5 10335 187.5 2 2 270 30 15 20 6 6
6 10228 187.5 2 2 270 −25 0 65 6 5
7 8327 202.5 3 2 260 25 10 35 5 4
8 534 283.0 4 3 360 60 −35 75 20 66
9 10041 171.0 1 1 260 55 −20 10 12 −9
10 9451 212.0 1 1 270 15 40 65 10 17
11 10234 192.0 2 2 260 65 30 60 9 13
12 6066 240.0 3 3 270 −5 75 15 3 6
13 10692 157.5 1 2 270 15 5 25 7 0
14 10587 137.0 2 2 290 10 0 50 5 19
15 8921 158.0 4 2 260 −10 5 110 5 15
16 10351 202.0 2 1 310 −35 5 5 −2 2
17 8998 209.0 4 1 260 −10 15 125 6 8
18 10465 167.0 2 2 270 20 20 70 13 10
19 9965 217.0 3 3 250 65 45 35 8 92
20 9752 218.5 3 1 260 35 20 35 13 49
R² (with #fibers): 0.62* 0.41* 0.34* 0.20 0.04 0.01 0.14 0.18 0.15
Table 2. Absolute values as well as regression coefficients (R²) of the associations of the number of open fibers 
with the post dialysis measurements and scorings, and with the interdialytic changes in registered machine 
parameters in the 20 dialysis sessions. *p < 0.05; #number; TMP: transmembrane pressure; BVM: blood volume 
monitoring; OCM: online clearance monitoring.
Figure 2. Associations between the number of fibers and a selection of different registered parameters: dialyzer 
dry mass (panel A), visual scoring of dialyzer (panel B), post minus pre dialysis TMP (panel C), and pre minus 
post dialysis OCM (panel D).
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standard to assess and compare thrombogenicity of different dialyzers and/or anticoagulation strategies. Ideally, 
such technique quantifies the patency of the individual fibers in the complete dialyzer, to assess the impact of 
coagulation on the dialyzer performance. The technique should be repeatable, accurate and operator-independent 
(objective). The here presented micro-CT scanning technique fulfills these criteria. It allows consistent and reli-
able counting of open versus blocked fibers in an accurate and repeatable way, as demonstrated by the agreement 
of measurements at different cross-sections of the dialyzer. In addition, this high accuracy is independent of the 
threshold chosen to define patency of fibers.
The present technique offers multiple advantages over the currently available methods to assess the degree of 
fiber blocking. So far, visual assessment has been most frequently promoted to assess coagulation of dialyzers. 
In this technique, a visual assessment of the discoloration of the fibers from white to red by residual (clotted and 
blocking) blood is done to estimate the degree of fiber blocking within the dialyzer. Despite existence of tools to 
enhance standardization, such as calibrated reference pictures, this simple method remains operator-dependent. 
This operator-dependency can theoretically be decreased by using computer analysis of pictures of the dialyzer 
rather than visual assessment by the human eye. However, still then the technique allows only assessment of fibers 
at the outside of the dialyzer, as more internal fibers cannot be visualized. As coagulation is not homogenous, this 
can result in big discrepancies between estimated and true degree of coagulation. This is more of importance as 
coagulation can occur at specific areas exactly because of the design of the dialyzer, for example at places of high 
turbulence, or stagnation of flow. The lack of capacity to assess the complete cross-section by visual assessment 
can thus lead to misinterpretation of the advantage/disadvantage of certain designs or strategies. Micro-CT eval-
uation is performed on complete sections of the dialyzer, allowing assessment of all fibers, irrespective of their 
location. Last, visual scoring of clotting can be hampered by non-transparent fiber and housing design, and can 
thus not be used in all types of dialyzers while the presented micro-CT technique is independent of the type of 
housing. In our study, there was a relatively good association between the visual score of the hemodialyzer and 
the number of blocked fibers (R² = 0.36) (Table 2 and Fig. 2 panel B). However, the point prevalence power of 
the visual score to predict the number of open fibers in individual dialyzers was disappointing. For example, a 
visual score of 3 corresponded with 6000 in one and 10000 open fibers in another dialyzer, whereas 10000 open 
fibers resulted in a visual score of 1 in one and 3 in another dialyzer (Fig. 2 panel B), making that visual scoring is 
completely not reliable at the level of the individual patient.
Dialyzer mass after post dialysis rinsing could be used as a proxy of blocked fibers. This method is based on 
the postulate that it is impossible to remove debris and blood from blocked fibers, so that more mass corresponds 
with more blocked fibers. In our experiments, post dialysis dialyzer mass corresponded best of all parameters 
with the number of open fibers as assessed by micro-CT, with an R² of 0.62 (Table 2 and Fig. 2 panel A). However, 
also here, the point prevalence predictive power was disappointing and insufficient to accept post dialysis dialyzer 
mass as an acceptable surrogate for degree of fiber blocking.
Laboratory markers for coagulation activation have been used to assess degree of coagulation during a hemo-
dialysis session. However, there is a lack of standardization of how these tests should be performed and how results 
should be interpreted. More important, the results of these tests are representing coagulation in the complete system, 
including the patient. As such, it is unclear from these tests where exactly the coagulation cascade has been activated, 
either in the patient, for example due to inflammation, or in the dialyzer. As a consequence, these tests are less 
informative about the impact of dialyzer design or anticoagulation strategy on the blocking of fibers.
In many centers, parameters that are routinely available from the dialysis machine, such as venous pressure 
and estimated transmembrane pressure are being used to assess the degree of fiber blocking. From the regres-
sion analyses, we found that none of these monitor derived parameters accurately reflects degree of coagulation. 
Pre-dialyzer pressure and measured transmembrane pressure potentially would perform better, but none of these 
parameters is provided on the presently commercially available dialysis machines.
Also the volume needed to achieve clean rinse-back, as determined by a sensor on the venous blood line or 
chamber, seems not to be able to predict the number of blocked fibers. This corresponds with the observation that 
visual inspection of blood lines and chambers does not necessarily reflect coagulation within the dialyzer.
This study also showed for the first time that online clearance monitoring (OCM), claimed to be an indicator 
of dialysis performance, does not correspond with the degree of fiber blocking during dialysis. For example, in 
a dialyzer ending up with only 534 patent fibers out of more than 10000 at start, (as shown in Fig. 1, lower right 
image), OCM values were only decreased by 28% after the 4 hour dialysis session. Although dialyzer clotting is 
an important issue in clinical practice, dialysis machines do thus not provide any parameter to accurately predict 
progressive coagulation in the extracorporeal circuit.
The micro-CT technique does not allow mechanistic assessment of underlying causes of fiber blocking at the 
molecular level. This would require much higher resolutions than what is achieved in the current set-up. Such higher 
resolution would be at the expense of the fact that the current set-up of the micro-CT scan allows to visualize the 
complete cross-section of the dialyzer, as it would necessitate analysis of processes at the level of membrane pores. 
As the main goal of the current micro-CT set-up was to evaluate the impact of different dialyzer designs and/or 
anticoagulation strategies on the clinical performance of the dialyzer, the current resolution allowing to determine 
blocking at the level of individual fibers is sufficient. However, the current set-up could also be used to indirectly 
explore underlying pathophysiology of coagulation, by comparing different strategies, for example with or without 
addition of antibodies21 blocking specific coagulation pathways, and assess their impact on filter blocking.
In conclusion, there is a need for a gold standard to assess blocking of hemodialyzers at the level of indi-
vidual fibers if we want to evaluate progress in the development of new strategies to reduce coagulation during 
hemodialysis. Advantage of strategies or designs claiming to improve anticoagulation over existing practice can 
be demonstrated or refuted by using this gold standard. The micro-CT approach also offers new perspectives 
for research on coagulation regimens in renal replacement therapies. Much needed online surrogate markers of 
coagulation can be validated against this method.
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Patients and Methods
This single center, open-label, non-controlled prospective trial included twenty adult patients (11 male) under-
going 245 ± 20 min maintenance hemodialysis (pressure controlled on-line postdilution hemodiafiltration, 
replacement fluid 20 ± 4 L). The median age was 75 [69–79]. Median weight was 65 [58–72] kg. Diabetic and 
hypertensive nephropathy were the most frequent underlying diseases. Sixty percent of the patients received anti-
platelet therapy. Table 3 lists the patient’s clinical characteristics and baseline laboratory findings.
The protocol was approved by the ethics committee of the Ghent University Hospital, and written informed 
consent was obtained from all included patients or their legal representatives (EC 2016/0908–B670201629247).
Dialysis and anticoagulation. All dialysis treatments were performed in accordance with the relevant 
guidelines and regulations. Patients received their standard Low-Molecular-Weight Heparin (Enoxaparin, 
Sanofi Belgium or Tinzaparin, Leo Pharma, Belgium) anticoagulation at the beginning of the dialysis session. 
All sessions were performed with single-use high flux FX600 Cordiax® polysulfone dialyzers with a surface area 
of 1.6 m² on 5008 dialysis machines (Both Fresenius Medical Care, Bad Homburg, Germany). Blood flow was 
maintained between 200 and 350 ml/min (297 ± 43), while ultrafiltration was set according to the patient’s inter-
dialytic weight gain and clinical status (509 ± 194 ml/h). In all dialysis sessions, double-needle vascular access 
was achieved through a native arteriovenous fistula or a well-functioning double lumen tunneled central venous 
catheter.
Online dialysis machine parameters. Different dialysis parameters as reported by the dialysis machine 
were registered every 30 min: i.e. venous and arterial pressure, transmembrane pressure (TMP), blood volume 
monitoring (BVM) and online clearance monitoring (OCM). For further regression analyses, absolute changes, 
calculated as post versus predialysis values, were used. Rinse-back volume, representing the volume of dialysate 
needed to restore all extracorporeal blood back to the patient at the end of the session was registered from the 
dialysis monitor.
Median [Q1; Q3] and (min; max) or n (%)
Cause of ESRD no. (%)
 Diabetic/hypertensive nephropathy 7 (35%)
 Post-Renal Causes 3 (15%)
 Glomerulonephritis 4 (20%)
 Others 6 (30%)
Co-existing illnesses no. (%)
 Smoking 2 (10%)
 History of cancer 7 (35%)
 Diabetes 6 (30%)
 Thromboembolic Venous Disease 5 (25%)
Antithrombic therapy—no. (%)
 Aspirine (monotherapy) 11 (55%)
 Clopidogrel (monotherapy) 0
 Aspirine and Clopidogrel 1 (5%)
 Vitamin K antagonist 3 (15%)
Dialysis LMWH anticoagulation
 No anticoagulation 1 (5%)
 Enoxaparin 20 mg 1 (5%)
 Enoxaparin 40 mg 4 (20%)
 Enoxaparin 60 mg 4 (20%)
 Tinzaparin 2500 U 2 (10%)
 Tinzaparin 3500 U 5 (25%)
 Tinzaparin 4500 U 3 (15%)
Clotting Parameters (mean + −SD)
 Hemoglobin, g/dl 9.8 [8.7–11.8] (7.9–13.5)
 Hematocrit, % 31.0 [27.7–36.0] (22.8–41.6)
 Platelets, x 10E3/µL 179 [115–255] (43–431)
 Prothrombin time (PT) 86 [69–102] (21–115)
 International Normalized Ratio (INR) 1.1 [1.0–1.3] (0.9–3.6)
Access
 Arteriovenous fistula 7 (35%)
 Permanent dialysis catheter 13 (65%)
Table 3. Patient characteristics and baseline laboratory data.
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Dialyzer and venous chamber scoring. Hemodialyzers and blood lines were removed immediately 
once the post-dialysis standard rinsing procedure had been completed. Subsequently, a member of the nurs-
ing staff and a clinician independently scored the extent of clotting in the dialyzer and the venous chamber in 
a semi-quantitative way using a reference scoring system10. Dialyzers were graded having no signs of clotting 
(1), few dark red fibers (2), less than 50% dark red fibers (3) or overall redness with >50% dark red fibers (4). 
Thrombus formation in the air bubble catcher (venous chamber) was quoted using a four graded scale: no detect-
able clotting (1), minimal clot formation (2), clots up to 5 cm but dialysis still possible (3), and complete occlusion 
of the air bubble catcher (4) (Table 4).
Next, in an in vitro setting, continuous subtle positive pressure ventilation was applied to the dialyzer both 
through the blood inlet as through the dialysate outlet for 24 hours, to dry the dialyzer membrane. Finally, dia-
lyzer dry mass was measured using a precise scale (CT 6000, Ohaus®, USA - calibration by Eldon Enterprises 
France).
Micro-CT scanning. Dialyzer fiber clotting was visualized using a 3D CT scanning technique on microm-
eter resolution. HECTOR is a High Energy CT scanner Optimized for Research22, built by the Ghent University 
Centre for X-ray Tomography (UGCT) in collaboration with the UGCT spin-off company XRE (Gent, Belgium). 
In front of the X-ray source, the dialyzer was mounted vertically on a precision rotation stage, and radiographies 
were recorded over 360° with an angular interval of 0.15°. Scan conditions were optimized to maximize the 
signal-to-noise ratio based on the sample size and structure, and the scanner properties. The tube voltage was set 
at 80 kV, at a power of 20 Watts, the maximal power that allowed imaging at a resolution of 25 µm. A total of 2401 
projections were recorded with 500 ms exposure each, resulting in a total exposure time of 20 minutes. Acquired 
images at 0 (projection 1) and 360° (projection 2401) were compared to exclude movement of the hemodia-
lyzer during the scanning process. Reconstruction of the raw projection data is performed with the Octopus 
Reconstruction software package, licensed by XRE23. This resulted in two types of images as presented in Fig. 3: 
fibers are visible as rings for cross-sections in the free fiber bundle (left panel), and as black dots for cross-sections 
in the dialyzer potting (right panel), a polyurethane sealing near the blood inlet and outlet, fixing the ends of the 
capillary fibers.
Fiber counting and coagulation quantification. Fibers were counted in the central cross-section of the 
dialyzer outlet potting (reference slice) since this region offers optimal visualization of air inflated open fibers, 
appearing as black dots (Fig. 3–right panel). These dots can easily be counted in a computer-based way, in contrast 
to the use of cross-sectional images taken out of the potting showing fibers as white cylinders (Fig. 3–left panel).
Clotting score dialyzer Number of dialyzers (%)
1 Clean filter 4 (20)
2 Few dark red fibers 7 (35)
3 <50% dark red fibers 5 (25)
4 >50% dark red fibers 4 (20)
Venous chamber scoring
1 no detectable clotting 7 (35)
2 minimal clot formation 9 (45)
3 clots up to 5 cm but dialysis still possible 4 (20)
4 complete occlusion of the air trap 0 (0)
Table 4. Visual clotting scores.
Figure 3. CT images of cross-sections in the same used dialyzer halfway the dialyzer (left panel) and at the 
central cross-section in the outlet potting (right panel). Central fibers are open and peripheral fibers are 
blocked. Sections in the potting offer optimal visualization of air inflated open fibers, appearing as black dots.
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The non-coagulated fibers (i.e. black dots) were counted using the Fiji image processing toolkit of ImageJ 
analysis software24,25 (ImageJ 1.51 H, NIH, Bethesda, USA), an open-source platform for biological-image anal-
ysis26 (Fig. 4). To ameliorate selection and count of the patent fibers, the brightness of each individual image was 
optimized using image thresholding27 (Fig. 4–panel B). The region of interest (ROI) was selected bordering the 
entire fiber bundle to avoid count of any disturbances outside the fiber bundle (Fig. 4–panel B). Watershed seg-
mentation was employed to distinguish sticky fibers28. Image particles with a circularity of 0.5–1 were selected 
(Fig. 4–panel C).
Based on the reference images of the non-used dialyzers, only fibers with a surface area of >70% (thresh-
old) of the cross section of a non-used fiber were considered to be open. This correlates with a surface area of 
0.0204 mm². Validity and reliability of the method were checked, the former by comparing the impact of dif-
ferent arbitrary thresholds (60 and 80% open fiber) to define open fibers, the latter by performing counts in a 
cross-section 100 slices (i.e. 2.5 mm) proximal of the reference slice.
Statistical analysis. Statistical analyses were performed using SPSS (version 24, SPSS Inc, Chicago, USA). 
Continuous variables were summarized as mean ± SD if normally distributed (normality was checked with 
Shapiro-Wilk test); otherwise median value with interquartile range [IQR] were reported. Categorical variables 
were expressed as frequencies and percentages. Regression analyses were performed (R²) with the number of 
open fibers as independent variable and the dialysis parameters as dependent variables.
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